Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markers

J Immunother. 2012 Nov-Dec;35(9):661-9. doi: 10.1097/CJI.0b013e318270e112.

Abstract

Viral infections with cytomegalovirus (CMV) or human adenovirus (HAdV) after stem cell transplantation are still associated with a high morbidity and mortality. Transfer of T-cell immunity from a healthy individual to a stem cell transplant recipient, known as adoptive T-cell transfer, has been shown to be effective to prevent viral complications. Treatment efficacy will depend on the availability of functional T-cell lines with a strong T(helper)1 response. Ex vivo isolation of antigen-specific T cells could be performed on the basis of the cytokine capture technique or antigen-induced expression of activation markers. In this study, we compare the specificity, expansion/differentiation potential, and T(helper)1 response against CMV and HAdV after different isolation strategies. Antigen-specific T cells from healthy donors were isolated by antigen-induced expression of IFN-γ and/or CD137 after stimulation with the viral antigens hexon (HAdV) or pp65 (CMV). Isolation of antigen-specific T cells based on the expression of activation markers is feasible and less time consuming, but in contrast to isolation based on IFN-γ secretion, it leads to a reduction of T(helper)1 cells. Both isolated CD137(+) and isolated IFN-γ(+) T cells mainly consist of CD4(+) T(CentralMemory) and T(EffectorMemory) cells with high expansion potential and effective cytokine production. CD154(+) is mainly expressed on CD4(+)T cells and shows coexpression with IFN-γ on activated T cells, which cannot be found for CD137(+) cells. In conclusion, T-cell lines could be easily generated on the basis of IFN-γ(+) and/or expression of the activation marker CD137 but both approaches result in different T-cell populations, which may lead to divergent T-cell responses in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Viral / immunology*
  • CD4-CD8 Ratio
  • CD40 Ligand / metabolism
  • Capsid Proteins / immunology
  • Cell Line
  • Cytotoxicity, Immunologic
  • Epitopes, T-Lymphocyte / immunology
  • Humans
  • Immunotherapy, Adoptive
  • Interferon-gamma / metabolism*
  • Lymphocyte Activation / immunology*
  • Phenotype
  • Phosphoproteins / immunology
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism
  • T-Lymphocytes / cytology
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism
  • Th1 Cells / immunology*
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / metabolism
  • Viral Matrix Proteins / immunology

Substances

  • Antigens, Viral
  • Capsid Proteins
  • Epitopes, T-Lymphocyte
  • Phosphoproteins
  • Tumor Necrosis Factor Receptor Superfamily, Member 9
  • Viral Matrix Proteins
  • cytomegalovirus matrix protein 65kDa
  • hexon capsid protein, Adenovirus
  • CD40 Ligand
  • Interferon-gamma